Axent Biosciences

📍 Berkeley, United States👥 15 employees💰 Last funded Jul 2024
Biotechnology🌐 axentbio.com
Website LinkedIn
Axent Biosciences develops next generation stem cell therapies to address unmet medical needs in human health. Spun out of Prof. David Schaffers Lab at UC Berkeley, Axents platform technologies in stem cell manufacturing and implantation leverage 20+ years of stem cell expertise and 10+ years of biomaterials engineering to overcome major bottlenecks in the clinical development pipeline to efficiently provide high quality stem cell therapeutics to large populations of patients in need.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Axent Biosciences?
Axent Biosciences has 1 investors on record on gritt.io.
When did Axent Biosciences last raise funding?
The most recent investment in Axent Biosciences recorded on gritt.io was in July 2024.
What industry is Axent Biosciences in?
Axent Biosciences operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Axent Biosciences based?
Axent Biosciences is headquartered in Berkeley, United States.